Form 8-K MEDIFAST INC For: Dec 08

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

        

Date of Report (Date of earliest event reported): December 8, 2016

 

MEDIFAST, INC.

(Exact name of registrant as specified in its Charter)

 

Delaware		001-31573		13-3714405
(State or other jurisdiction		(Commission file number)		(IRS Employer
of incorporation)				Identification No.)
3600 Crondall Lane, Owings Mills, Maryland (Address of Principal Executive Offices)				21117 (Zip Code)

 

Registrant’s telephone number, including area code: (410)-581-8042

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

  

Item 8.01.

Other Events.

 

On December 8, 2016, Medifast, Inc. issued a press release announcing the declaration of a cash dividend by the company’s Board of Directors. The full text of the press release is attached as Exhibit 99.1.

 

Item 9.01.

Financial Statements and Exhibits.

 

(d)

Exhibits.

 

99.1

Press release dated December 8, 2016 titled “Medifast, Inc. Announces 28 Percent Increase in Quarterly Dividend”

  

  

Signature

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

	MEDIFAST, INC.
	By:	/s/ Timothy Robinson
		Timothy Robinson Chief Financial Officer
Dated: December 8, 2016

  

  

EXHIBIT INDEX

 

	Exhibit No.	Description
	99.1	Press Release dated December 8, 2016 titled “Medifast, Inc. Announces 28 Percent Increase in Quarterly Dividend”

 

Exhibit 99.1

 

 

  

Medifast, Inc. Announces 28 Percent Increase in Quarterly Dividend

 

OWINGS MILLS, Md., December 8, 2016 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that its Board of Directors has declared a $0.32 quarterly cash dividend to its stockholders, reflecting a $0.07 or 28% increase over the previous quarter’s cash dividend. The quarterly cash dividend of $0.32 per share is payable on February 9, 2017 to stockholders of record as of the close of business on December 23, 2016.

 

The Company expects to maintain a program of paying dividends on a quarterly basis. However, the declaration of dividends in the future is subject to the discretion of the Medifast Board of Directors, who will evaluate the Company's dividend program from time to time based on factors that it deems

relevant.

 

About Medifast

 

Medifast (NYSE: MED) is a leading provider of easy-to-use, clinically proven, weight-loss and healthy living products and programs. Medifast aims to help customers lead a healthier lifestyle through a holistic approach to weight-loss and weight management, nutrition education and fitness. Medifast's proven results are based on the use of structured meal plans featuring Medifast Meals, which are nutritionally designed to assist customers with successful weight-loss and weight management. The company sells its products and programs via four distribution channels: 1) the web and national call centers, 2) the Take Shape For Life® personal coaching division, 3) Medifast Weight Control Centers®, and 4) a national network of physicians.  Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto www.MedifastNow.com.

 

MED-F

 

Forward Looking Statements

 

This release contains "forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These “forward-looking” statements are based on present circumstances and on Medifast's predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements, including the expected future payment of dividends and any statement of the plans and objectives of management for future operations and forecasts of future growth and value, are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. Such forward-looking statements are made only as of the date of this release and Medifast assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements.

 

Investor Contact:

 

ICR, Inc.

 

Katie Turner

 

(646) 277-1228

 

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint
• AFC Announces Financial Results for the Second Quarter 2026
• Bravada Corporate Update